New Vaccine Push & GOP Plans | 8.30.22
Morning Wire
00:00
Concerns Over New COVID Vaccine
This chapter addresses the imminent release of a COVID vaccine for the Omicron variant BA.5, examining FDA approvals based on limited data and raising safety concerns. It highlights the potential risks of immune imprinting and adverse reactions, particularly in younger populations, amid a shifting political landscape.
Play episode from 01:32
Transcript
